Skip to main content

Table 1 Systematic variation from consensus DR1-type PPRE

From: Meta-analysis of primary target genes of peroxisome proliferator-activated receptors

Percent binding strength

PPRE position

 

1

2

3

4

5

6

7

8

9

10

11

12

13

PPARα

   Consensus (90-100)

A/G

G

G

T

A/C

A

A

A

G

G

T

C

A

   Class I (60-90)

T

 

C

 

G

 

T

G

 

T

C/G

A/G

G

   Class II (30-60)

C

T

A/T

A/C/G

T

T

C/G

C

A/C/T

  

T

C/T

   Class III (0-30)

 

A/C

   

C/G

 

T

 

A/C

A

  

PPARγ

   Consensus (90-100)

A/G

G

G

T

C/G

A

A

A

G

G

T

C

A

   Class I (60-90)

   

C/G

A/T

 

T

G

 

T

C/G

A/G/T

G

   Class II (30-60)

C/T

A/T

T

A

  

C

C

A/C/T

   

C/T

   Class III (0-30)

 

C

A/C

  

C/G/T

G

T

 

A/C

A

  

PPARβ/δ

   Consensus (90-100)

A/G

G

G

T

C

A

A

A

G

G

T

C

A

   Class I (60-90)

   

C/G

G/T

 

T

G

 

T

 

G/T

 

   Class II (30-60)

C

A/T

T

A

A

   

A/T

 

C/G

A

G/C/T

   Class III (0-30)

T

C

A/C

  

C/G/T

C/G

C/T

C

A/C

A

  
  1. The binding strengths of in vitro translated PPAR-RXR heterodimers to 39 systematic variations of the DR1-type consensus PPRE AGGTCAAAGGTCA were determined by gelshift assays in reference to this consensus PPRE. Based on their average binding strength, all variations are sorted into three classes.